Total Payments
$1,496
2024 Payments
$169.36
Companies
25
Transactions
92
Medicare Patients
2,059
Medicare Billing
$194,929
Payment Breakdown by Category
Food & Beverage$1,496 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,496 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $282.32 | 18 | $0 (2024) |
| ABBVIE INC. | $223.78 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $186.39 | 11 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $120.38 | 8 | $0 (2019) |
| PFIZER INC. | $95.85 | 6 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $69.68 | 5 | $0 (2022) |
| Novo Nordisk Inc | $68.02 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $50.42 | 4 | $0 (2019) |
| Lilly USA, LLC | $47.81 | 3 | $0 (2020) |
| Abbott Laboratories | $43.95 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.36 | 8 | ABBVIE INC. ($95.04) |
| 2023 | $183.47 | 10 | AbbVie Inc. ($49.11) |
| 2022 | $231.76 | 13 | ABBVIE INC. ($60.93) |
| 2021 | $18.70 | 1 | AbbVie Inc. ($18.70) |
| 2020 | $77.71 | 5 | Amgen Inc. ($19.59) |
| 2019 | $125.34 | 8 | E.R. Squibb & Sons, L.L.C. ($37.60) |
| 2018 | $285.57 | 18 | Amgen Inc. ($76.47) |
| 2017 | $403.78 | 29 | Amgen Inc. ($84.95) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/14/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Endocrinology | ||||||
| 01/23/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/09/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: UROLOGY | ||||||
| 09/27/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Bone Health | ||||||
| 01/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Bone Health | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Diabetes Care | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Bone Health | ||||||
| 10/06/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Obesity | ||||||
| 08/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2022 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $23.76 | General |
| 06/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 429 | 658 | $88,051 | $46,598 |
| 2022 | 10 | 433 | 691 | $95,560 | $49,578 |
| 2021 | 6 | 502 | 840 | $84,326 | $46,167 |
| 2020 | 22 | 695 | 988 | $115,229 | $52,586 |
Total Patients
2,059
Total Services
3,177
Medicare Billing
$194,929
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 353 | $50,060 | $26,621 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 104 | 104 | $23,681 | $12,180 | 51.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 54 | 55 | $5,885 | $3,920 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 27 | $2,288 | $1,383 | 60.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 61 | $1,403 | $1,285 | 91.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 22 | $1,121 | $611.17 | 54.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $429.00 | $375.70 | 87.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 23 | $3,184 | $221.97 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 415 | $60,462 | $30,860 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 70 | 70 | $17,360 | $8,603 | 49.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 47 | 47 | $4,794 | $3,232 | 67.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 12 | $3,430 | $1,548 | 45.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,888 | $1,373 | 35.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 61 | $1,403 | $1,331 | 94.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 23 | $2,323 | $1,319 | 56.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $740.00 | $559.03 | 75.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $608.00 | $460.20 | 75.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 15 | 15 | $552.00 | $293.58 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 452 | $62,923 | $36,262 | 57.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $10,384 | $5,596 | 53.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 25 | $2,425 | $1,364 | 56.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 67 | 67 | $3,350 | $1,355 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 68 | 68 | $1,564 | $1,047 | 67.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 146 | 184 | $3,680 | $543.00 | 14.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 158 | 381 | $51,709 | $23,632 | 45.7% |
About Dr. Mark Wantz, MD
Dr. Mark Wantz, MD is a Family Medicine healthcare provider based in Summersville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235128083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Wantz, MD has received a total of $1,496 in payments from pharmaceutical and medical device companies, with $169.36 received in 2024. These payments were reported across 92 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,496).
As a Medicare-enrolled provider, Wantz has provided services to 2,059 Medicare beneficiaries, totaling 3,177 services with total Medicare billing of $194,929. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Summersville, WV
- Active Since 10/14/2005
- Last Updated 04/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235128083
Products in Payments
- ELIQUIS (Drug) $176.80
- Prolia (Biological) $160.56
- ENTRESTO (Drug) $150.43
- EVENITY (Biological) $67.70
- XARELTO (Drug) $56.47
- TOUJEO (Drug) $50.42
- LINZESS (Drug) $49.40
- VRAYLAR (Drug) $48.33
- TRULICITY (Drug) $47.81
- FREESTYLE LIBRE 2 (Device) $43.95
- DALVANCE (Drug) $34.91
- UBRELVY (Drug) $33.53
- XIFAXAN (Drug) $33.30
- Vascepa (Drug) $31.06
- QUTENZA (Drug) $30.55
- CHANTIX (Drug) $27.73
- SHINGRIX (Biological) $26.81
- QULIPTA (Drug) $24.75
- LEQVIO (Drug) $21.19
- Otezla (Drug) $19.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Summersville
Dr. Michael Taylor, Md, MD
Family Medicine — Payments: $4,578
Family Medicine $4,578
Dr. Richard Trenbath, M.d, M.D
Family Medicine — Payments: $2,276
Family Medicine $2,276
Kathy Hamon, Do, DO
Family Medicine — Payments: $1,896
Family Medicine $1,896
Bruce Greenberg, Md, MD
Family Medicine — Payments: $1,833
Family Medicine $1,833
Margaret Wantz, Md, MD
Family Medicine — Payments: $1,115
Family Medicine $1,115
Sunita Greenberg, Md, MD
Family Medicine — Payments: $1,081
Family Medicine $1,081